Hemoadsorption in septic shock - CON.

COI Statement

Declarations. Conflicts of interest: GM has received honoraria for speaking at conferences from Estor and Fresenius; TM and DS have no conflict of interest to declare.

References:

• Girardis M, David S, Ferrer R et al (2024) Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med 50:1580–1592. https://doi.org/10.1007/s00134-024-07586-2
• Conway Morris A, Rynne J, Shankar-Hari M (2022) Compartmentalisation of immune responses in critical illness: does it matter? Intensive Care Med 48:1617–1620. https://doi.org/10.1007/s00134-022-06871-2
• van Amstel RBE, Kennedy JN, Scicluna BP et al (2023) Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes. Intensive Care Med 49:1360–1369. https://doi.org/10.1007/s00134-023-07239-w
• Chen J-J, Lai P-C, Lee T-H, Huang Y-T (2023) Blood purification for adult patients with severe infection or sepsis/septic shock: a network meta-analysis of randomized controlled trials. Crit Care Med 51:1777–1789. https://doi.org/10.1097/CCM.0000000000005991
• Cruz DN, Antonelli M, Fumagalli R et al (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301:2445–2452. https://doi.org/10.1001/jama.2009.856